Delivery Order SPE2DB22D2009-SPE2DB24FL7QG
Award Date 1/7/24
Potential Completion Date 1/8/24
Potential Value $1.5K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,714,600 units of Ondansetron HCl 8 mg tablets. The contract has a completion date of February 21, 2024 and a potential value of $1,287.79. This delivery order is part of a larger Indefinite Delivery Contract (IDC) awarded solely to Amerisourcebergen Drug Corp by DLA, with a potential value of $999,999,999.00 and...
- The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a for-profit subsidiary of Amerisourcebergen Corporation, to provide Ondansetron HCl 8 mg tablets. The $4,310.25 contract has a completion date of February 23, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00 through December 2025, which serves as the primary vehicle for the company to deliver pharmaceuticals and...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of Ondansetron HCL 8 mg tablets. The $2,780.75 contract has a completion date of February 2, 2024. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, which is part of a larger indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen with a potential...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $9,289.15 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide Ondansetron HCL 8 mg tablets. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp by DLA with a potential value of $999,999,999.00 through December 31, 2025. The IDC serves as the primary contract vehicle for Amerisourcebergen to deliver...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of Ondansetron HCL 8 mg tablets. The contract has a ceiling value of $52,431.65 and a period of performance through March 29, 2024. This delivery order falls under a larger indefinite delivery contract (IDC) held by AmerisourceBergen Drug Corp with a potential value of $999,999,999.00 and a performance period through...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The delivery order, valued at $1,135.44, is for the supply of Ondansetron HCL 4 MG Tablets to support military and government healthcare programs. The contract has an ultimate completion date of November 27, 2023, and is a firm-fixed-price delivery order. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds a significant...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,567,539,699 units of Ondansetron HCL 8 mg tablets. The firm-fixed-price contract has a ceiling value of $2,076.54 and a completion date of March 12, 2025. The award is not designated under any set-aside program. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
- The Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract worth $3,048.23 to AmerisourceBergen Drug Corp, a subsidiary of the pharmaceutical distribution company Cencora, Inc. dba AmerisourceBergen. The contract is for the delivery of Ondansetron HCL 4 mg tablets to support military treatment programs and facilities. This delivery order is issued under an indefinite delivery contract (IDC) with a potential value of $999,999,999.00 and a performance period...
- This federal contract award, valued at $7,307.67, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the delivery of 4,563,501,307 tablets of Ondansetron Hydrochloride 8 mg. The contract has an ultimate completion date of February 1, 2024 and is structured as a Firm Fixed Price Delivery Order. The award was made through full and open competition, with no set-aside designation. Amerisourcebergen Drug Corp holds a significant...
- The U.S. government agency the Defense Logistics Agency (DLA) Troop Support Medical has awarded a $11,980.91 firm-fixed-price delivery order (SPE2DX23F2HZY) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the supply of 4,560,975,954 units of 4 mg Ondansetron HCL tablets. The delivery order has a completion date of May 19, 2023 and was awarded on May 18, 2023. This delivery order is part of a larger indefinite delivery contract (IDC) valued at up to...